Saltar al contenido
RecuperaciónArtículo de investigación3 min read

Wearable HRV dips before menstruation, and lower HRV tracked worse symptoms in women with PMDs

Colectivo editorial MoveVitals · Study published · Reading updated

Original paper:Wearable-measured heart rate variability and premenstrual disorder symptoms across menstrual cycle. · Archives of women's mental health · 2026 · Artículo original ↗

Idea principal

In 193 women wearing a Huawei fitness tracker, HRV (SDNN, rMSSD, HF) fell before menses and rose afterwards, and in the 68 women with premenstrual disorders lower HRV in the weeks around menses went with worse symptoms (rMSSD, postmenstrual week β = -0.036 per SD), unlike in women without. Only 1-2 cycles were tracked, and the finding is an association, not a screening test.

Study design

Artículo de investigación

Reading basis

Published abstract

Reading focus

Design & applicability

Esta explicación editorial está disponible en inglés, chino simplificado y chino tradicional. Esta interfaz muestra la lectura en inglés.

Pregunta de investigación

Premenstrual disorders (PMDs) are hard and slow to screen for, so detection and treatment are delayed. The authors asked how wearable-measured heart rate variability (HRV) changes across the menstrual cycle, and whether it relates to daily PMD symptoms, as a possible digital marker.

Población y método

Prospective study of female participants nested in the Care of Premenstrual Emotion Cohort. Daily HRV metrics were collected with a Huawei Fitness Tracker over 1-2 menstrual cycles, and PMD symptoms were rated daily with the Daily Record of Severity of Problems. HRV across the cycle was described with descriptive statistics and splines, and associations with symptoms were estimated with a mixed-effect model.

Resultados

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    The analysis included 193 participants (68 with prospectively confirmed PMDs) and 293 menstrual cycles.
  2. 2
    In women with and without PMDs, SDNN, rMSSD and HF decreased before menses and increased afterwards; the rise was more pronounced in women without PMDs.
  3. 3
    In the week before or after menses, these HRV metrics were inversely associated with symptoms among women with PMDs (e.g., rMSSD, postmenstrual week, β = -0.036 per SD, 95% CI -0.065 to -0.048).
  4. 4
    Women without PMDs showed a null association (β = -0.001, 95% CI -0.011 to 0.009; P-for-difference < 0.001).

Límites e incertidumbre

  1. 1
    Only 68 women had confirmed PMDs, and each was followed for 1-2 cycles, so patterns are less certain than a longer follow-up would give.
  2. 2
    HRV came from one brand of consumer tracker (Huawei), which may not match other devices or clinical HRV.
  3. 3
    The abstract reports associations only, so it cannot say whether low HRV drives symptoms or vice versa, and it did not test screening accuracy.
  4. 4
    This reading is based on the abstract only.

Relevancia práctica

This suggests HRV from a wearable moves with the menstrual cycle and may be tied to premenstrual symptoms, which could eventually support screening tools. It is not yet a way to diagnose PMDs; anyone with severe premenstrual mood symptoms should discuss them with a clinician.

Tus datos

If your device reports HRV overnight, it is normal to see it shift across your cycle, so compare the same cycle phase from month to month on the same device. Pairing it with a simple daily symptom log, as the study did, can make patterns clearer, but a single low reading says little.

Cómo interpretar la evidencia

The index does not establish a precise design. Read the methods before making causal claims; check population, comparator, outcomes and uncertainty in the source.

Resumen estructurado de los autores English

El resumen original en inglés se reproduce con atribución bajo la licencia indicada. Es una fuente, no una interpretación de MoveVitals. El análisis preparado figura arriba; verifica los resultados importantes en la fuente.

Background

Screening premenstrual disorders (PMDs) is time-consuming and challenging, resulting in delays in detection and treatment. To characterize the temporal dynamics of portable digital-marker across the menstrual cycle and its biological basis in PMDs, we investigated the menstrual fluctuation of wearable device-based real-time heart rate variability (HRV) through menstrual cycles and its associations with premenstrual disorders (PMDs) symptoms.

Methods

A prospective study of female participants nested from the Care of Premenstrual Emotion Cohort was conducted. Daily HRV metrics were collected by the Huawei Fitness Tracker over 1-2 menstrual cycles. PMDs symptoms were assessed with the Daily Record of Severity of Problems on a daily basis. HRV variability across cycles was described using descriptive statistics and splines, while associations between HRV metrics and PMDs symptoms were estimated using a mixed-effect model.

Results

In total, 193 participants (with 68 prospectively confirmed PMDs) were included, with measures from 293 menstrual cycles. In both women with and without PMDs, SDNN, rMSSD, and HF decreased before menses and increased afterwards; the increase trends were more pronounced in women without PMDs. During the week before or after menses, levels of these HRV metrics were inversely associated with PMDs symptoms among women with PMDs (e.g., rMSSD, postmenstrual week, β = -0·036 per SD, 95% CI: -0·065 to -0·048), whereas null association was noted for those without PMDs (β = -0·001, 95% CI -0·011 to 0·009; P-for-difference < 0·001).

Conclusions

Wearable device-estimated HRV fluctuate across menstrual cycles, with varying strengths of association with PMDs symptoms between individuals with and without PMDs, which may facilitate the development of digital biomarkers for future PMDs diagnostics.

Fuentes y atribución

Wearable-measured heart rate variability and premenstrual disorder symptoms across menstrual cycle.

Pan Q, Zhou J, Chen M, Zhang P, Shi X, Lin Y, Huang J, Li Y, Lu D.

Archives of women's mental health · 2026-07-07

DOI: 10.1007/s00737-026-01740-z ↗PubMed · 42412242 ↗Europe PMC · Licencia registrada: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

Interpretación editorial de MoveVitals · contenido educativo · sin revisión clínica individual registrada

Fuentes verificadas 2026-11-01

Guías prácticas

Leer en contexto

·Artículo de investigación

Short-term HRV was higher during slow breathing in 962 military men, injured or not

In 962 military men (median age 37.6 years), every short-term heart rate variability (HRV) measure was higher during slow breathing at six breaths a minute than during spontaneous breathing, injured or not; in fast resting breathers RMSSD rose from 15.57 to 21.89 ms. It was one session in a fixed order, so it shows an immediate effect, not lasting benefit.

European Journal of Applied Physiology

Explicaciones detalladasLeer estudio →
·Metaanálisis de ensayos

Cold-water immersion: no strength gain, briefly weaker jumps, soreness relief uncertain

Across 22 randomised trials (375 participants, mostly men), one cold-water immersion after exercise did not change maximal isometric strength (g 0.08, 95% CI −0.11 to 0.26) and was followed by weaker jumping straight afterwards (g −0.68), gone by 24–48 hours. Lower soreness and creatine kinase looked favourable but weakened in sensitivity checks, and certainty was low to very low.

PeerJ

Explicaciones detalladasLeer estudio →
·Revisión de evidencia

Cold-water immersion after hard exercise: less soreness, better power, no strength gain

In a meta-analysis of 52 randomised trials, cold-water immersion after high-intensity exercise was followed 24 hours later by lower soreness (SMD −0.89), higher perceived recovery (0.66) and better muscular power (0.22), with no effect on strength. Participants could not be blinded, most were men, and many pooled results rest on few studies with high heterogeneity.

Sports Medicine

Explicaciones detalladasLeer estudio →
·Métodos e interpretación

Acute:chronic workload ratio: no evidence it can reduce injury risk, authors argue

The authors argue there is no evidence for using the acute:chronic workload ratio (ACWR) in training-load management or to reduce injury risk: no study has properly estimated a causal effect, and the ratio is statistically inaccurate and ambiguous. This is a methodological critique, not a new data analysis, so it does not show that training load is unrelated to injury.

International Journal of Sports Physiology and Performance

Explicaciones detalladasLeer estudio →
Recuperación →